Trademark: 78450625
Word
SELFEMRA
Status
Dead
Status Code
710
Status Date
Friday, March 20, 2015
Serial Number
78450625
Registration Number
3490147
Registration Date
Tuesday, August 19, 2008
Mark Type
4000
Filing Date
Wednesday, July 14, 2004
Published for Opposition
Tuesday, August 30, 2005
Cancellation Date
Friday, March 20, 2015

Trademark Owner History
TEVA Pharmaceuticals USA Inc. - Original Registrant

Classifications
5 Pharmaceutical preparation indicated for the treatment of premenstrual dysphoric disorder

Trademark Events
Mar 20, 2015
Cancelled Sec. 8 (6-Yr)
Aug 19, 2008
Registered-Principal Register
Jul 15, 2008
Law Office Registration Review Completed
Jul 15, 2008
Assigned To Lie
Jul 14, 2008
Allowed Principal Register - Sou Accepted
Jun 6, 2008
Statement Of Use Processing Complete
Jun 2, 2008
Use Amendment Filed
Jun 2, 2008
Teas Statement Of Use Received
Apr 10, 2008
Extension 5 Granted
Mar 21, 2008
Extension 5 Filed
Mar 21, 2008
Teas Extension Received
Oct 5, 2007
Extension 4 Granted
Sep 26, 2007
Extension 4 Filed
Sep 26, 2007
Teas Extension Received
Jul 19, 2007
Extension 3 Granted
Apr 5, 2007
Extension 3 Filed
Apr 5, 2007
Teas Extension Received
Dec 5, 2006
Extension 2 Granted
Oct 18, 2006
Extension 2 Filed
Oct 18, 2006
Teas Extension Received
Apr 3, 2006
Extension 1 Granted
Mar 16, 2006
Extension 1 Filed
Mar 16, 2006
Teas Extension Received
Nov 22, 2005
Noa Mailed - Sou Required From Applicant
Aug 30, 2005
Published For Opposition
Aug 10, 2005
Notice Of Publication
Apr 25, 2005
Law Office Publication Review Completed
Apr 25, 2005
Assigned To Lie
Apr 1, 2005
Assigned To Lie
Mar 28, 2005
Approved For Pub - Principal Register
Mar 28, 2005
Teas/Email Correspondence Entered
Mar 22, 2005
Correspondence Received In Law Office
Mar 25, 2005
Teas Change Of Correspondence Received
Mar 22, 2005
Teas Response To Office Action Received
Feb 25, 2005
Non-Final Action E-Mailed
Feb 25, 2005
Non-Final Action Written
Feb 17, 2005
Assigned To Examiner
Jul 22, 2004
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24